The p110γ isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites

被引:41
|
作者
Thomas, Molly S. [1 ]
Mitchell, Jason S. [1 ]
DeNucci, Christopher C. [1 ]
Martin, Amanda L. [1 ]
Shimizu, Yoji [1 ]
机构
[1] Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol,Canc Ctr, Minneapolis, MN 55455 USA
关键词
inflammation; chemokines; leukocyte; activation; trafficking;
D O I
10.1189/jlb.0807561
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of PI-3K in leukocyte function has been studied extensively. However, the specific role of the p110 gamma isoform of PI-3K in CD4 T lymphocyte function has yet to be defined explicitly. In this study, we report that although p110 gamma does not regulate antigen- dependent CD4 T cell activation and proliferation, it plays a crucial role in regulating CD4 effector T cell migration. Nai r ve p110 gamma(-/-) CD4 lymphocytes are phenotypically identical to their wildtype ( WT) counterparts and do not exhibit any defects in TCR- mediated calcium mobilization or Erk activation. In addition, p110 gamma- deficient CD4 OT. II T cells become activated and proliferate comparably with WT cells in response to antigen in vivo. Interestingly, however, antigen- experienced, p110 gamma- deficient CD4 OT. II lymphocytes exhibit dramatic defects in their ability to traffic to peripheral inflammatory sites in vivo. Although antigen- activated, p110 gamma-deficient CD4 T cells express P- selectin ligand, beta 2 integrin, beta 1 integrin, CCR4, CXCR5, and CCR7 comparably with WT cells, they exhibit impaired Factin polarization and migration in response to stimulation ex vivo with the CCR4 ligand CCL22. These findings suggest that p110 gamma regulates the migration of antigen- experienced effector CD4 T lymphocytes into inflammatory sites during adaptive immune responses in vivo.
引用
收藏
页码:814 / 823
页数:10
相关论文
共 21 条
  • [1] Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections
    Gracias, Donald T.
    Boesteanu, Alina C.
    Fraietta, Joseph A.
    Hope, Jennifer L.
    Carey, Alison J.
    Mueller, Yvonne M.
    Kawalekar, Omkar U.
    Fike, Adam J.
    June, Carl H.
    Katsikis, Peter D.
    JOURNAL OF IMMUNOLOGY, 2016, 196 (03): : 1186 - 1198
  • [2] Phosphatidylinositol 3-kinase p110δ drives intestinal fibrosis in SHIP deficiency
    Lo, Young
    Sauve, Jean Philippe
    Menzies, Susan C.
    Steiner, Theodore S.
    Sly, Laura M.
    MUCOSAL IMMUNOLOGY, 2019, 12 (05) : 1187 - 1200
  • [3] p110γ and p110δ isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease
    Saudemont, Aurore
    Garcon, Fabien
    Yadi, Hakim
    Roche-Molina, Marta
    Kim, Nayoung
    Segonds-Pichon, Anne
    Martin-Fontecha, Alfonso
    Okkenhaug, Klaus
    Colucci, Francesco
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (14) : 5795 - 5800
  • [4] The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion
    Luk, Sze Ki
    Piekorz, Roland P.
    Nuernberg, Bernd
    To, Shing-Shun Tony
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (01) : 149 - 157
  • [5] The p110δ Isoform of Phosphatidylinositol 3-Kinase Controls the Quality of Secondary Anti-Leishmania Immunity by Regulating Expansion and Effector Function of Memory T Cell Subsets
    Liu, Dong
    Uzonna, Jude E.
    JOURNAL OF IMMUNOLOGY, 2010, 184 (06): : 3098 - 3105
  • [6] Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia
    Brown, Jennifer R.
    Byrd, John C.
    Coutre, Steven E.
    Benson, Don M.
    Flinn, Ian W.
    Wagner-Johnston, Nina D.
    Spurgeon, Stephen E.
    Kahl, Brad S.
    Bello, Celeste
    Webb, Heather K.
    Johnson, Dave M.
    Peterman, Sissy
    Li, Daniel
    Jahn, Thomas M.
    Lannutti, Brian J.
    Ulrich, Roger G.
    Yu, Albert S.
    Miller, Langdon L.
    Furman, Richard R.
    BLOOD, 2014, 123 (22) : 3390 - 3397
  • [7] Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation
    Yamaguchi, Hideki
    Yoshida, Shuhei
    Muroi, Emi
    Yoshida, Nachi
    Kawamura, Masahiro
    Kouchi, Zen
    Nakamura, Yoshikazu
    Sakai, Ryuichi
    Fukami, Kiyoko
    JOURNAL OF CELL BIOLOGY, 2011, 193 (07): : 1275 - 1288
  • [8] Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase α
    Echeverria, Ignacia
    Liu, Yunlong
    Gabelli, Sandra B.
    Amzel, L. Mario
    FEBS JOURNAL, 2015, 282 (18) : 3528 - 3542
  • [9] The p110α and p110β Isoforms of Class I Phosphatidylinositol 3-Kinase Are Involved in Toll-Like Receptor 5 Signaling in Epithelial Cells
    Ivison, Sabine M.
    Khan, Mohammed A. S.
    Graham, Nicholas R.
    Shobab, Leila A.
    Yao, Yu
    Kifayet, Arnawaz
    Sly, Laura M.
    Steiner, Theodore S.
    MEDIATORS OF INFLAMMATION, 2010, 2010
  • [10] Phosphoinositide 3-Kinase p110 Delta Differentially Restrains and Directs Naive Versus Effector CD8+ T Cell Transcriptional Programs
    Spinelli, Laura
    Marchingo, Julia M.
    Nomura, Aneela
    Damasio, Marcos P.
    Cantrell, Doreen A.
    FRONTIERS IN IMMUNOLOGY, 2021, 12